person

Lili Yang

Professor of microbiology, immunology and molecular genetics at UCLA and a member of the UCLA Broad Stem Cell Research Center and the UCLA Health Jonsson Comprehensive Cancer Center, working on stem cell-derived immune cell therapies.

Current clusters

science1 publisher

UCLA engineers a tumor receptor into cord blood stem cells before they mature into T cells

One dose controlled tumor growth in mouse models of ovarian cancer and melanoma. The safety case for the UCLA cells rests on a random receptor repertoire they never build. The work is in Cell Reports Medicine.

Publishers:sciencedaily.com

Reality

Evidence34
Adoption: Insufficient
Hype gap+34
Incentives72
Confidence46